Medically reviewed by Gagandeep Brar, MD Leukemias and lymphomas are often grouped together because they are both blood-related cancers that originate in lymphocytes. However, leukemia originates in ...

Galinpepimut-S therapy showed specific T-Cell immune responses for patients with acute myeloid leukemia in remission ...

such as ALL (acute lymphocytic leukemia), AML (acute myeloid leukemia), and CML (chronic myeloid leukemia). CLL is the most common leukemia in adults. Most people get diagnosed in their 60s and 70s.

Here is a select list of cancer therapies approved by the FDA throughout the month of January, featuring patient populations ...

They identified patients with lymphoid leukemia that switched to myeloid leukemia ... a PhD candidate in the Termini Lab at Fred Hutch Cancer Center. She studies how acute myeloid leukemia cells ...

January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.

Much work is needed to address inequities and gaps in care access for patients with acute myeloid leukemia (AML ... or refractory diffuse large B-cell lymphoma (DLBCL) that recently received ...

TCR-α/β and CD19 depleted stem cell grafts from haploidentical donors for allogeneic transplantation in patients with relapsed lymphoma ... refractory B-cell acute lymphoblastic leukemia ...